### Analysis

Procter & Gamble (P&G) reported its Q4 and full-year results, highlighting a 3% organic sales growth in the quarter. The company's focus on developed markets and developing markets, as well as its commitment to innovation, were emphasized. Key points include:

- **Organic Sales Growth**: 3% organic sales growth in Q4, with broad-based growth across multiple segments.
- **Developing Markets**: Developing markets now generate nearly 40% of sales and 45% of unit volume, with significant growth in key markets like China, Brazil, India, and Russia.
- **Developed Markets**: Developed market sales were down slightly, but trends should improve over the next six to nine months as plans are fully implemented.
- **Pricing**: Pricing contributed four points to organic sales growth, benefiting all five reporting segments.
- **Mix**: Mix reduced sales by 1 percentage point in the quarter due mainly to over-proportionate growth in developing markets.
- **Bottom Line**: Core earnings per share were $0.82, core tax rate was 22.4%, and net earnings were $1.24 per share, up 48% year-over-year.
- **Guidance**: Organic sales growth for 2013 is expected to be in the range of 2% to 4%, with core earnings per share in the range of $3.80 to $4.00.
- **Productivity**: The company is ahead of its target for reducing non-manufacturing enrollment and expects to achieve the majority of its initial 10% reduction target by the end of the calendar year.

### Conclusion

The short-term implications (1â€“2 weeks) for P&G's stock are likely to be positive, given the company's strong showing in Q4 and its commitment to growth in developing markets. The guidance for 2013 was in line with expectations, and the company's focus on innovation and cost savings should continue to drive growth. However, the stock may face some short-term pressure due to the uncertainty around the U.S. economy and the potential impact of the European financial crisis. Overall, the stock is likely to experience a positive impact in the short term.

**Rating: 1**